KininX Overview

  • Founded
  • 2013
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

KininX General Information


Provider of kinin pathological services intended for angioedema patients and clinical physicians. The company's offerings include offering expertise to on the kinin-kallikrein system to pharmaceutical companies developing medicines for the treatment of angioedema and diagnostic kits to prevent Angioedema, oedema, adverse reactions of medicines and anaphylactic reactions of transfusion of aphaeresis products, enabling patients to prevent inflammatory diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Primary Office
  • 8 Rue Duploye
  • 38100 Grenoble
  • France
+33 0 000 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KininX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Oct-2019 Completed Out of Business
1. Accelerator/Incubator 08-Jun-2015 Completed Startup
To view KininX’s complete valuation and funding history, request access »